BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Diagnosis
1347 results:

  • 1. PMFFNet: A hybrid network based on feature pyramid for ovarian tumor segmentation.
    Li L; He L; Guo W; Ma J; Sun G; Ma H
    PLoS One; 2024; 19(4):e0299360. PubMed ID: 38557660
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]    [Full Text] [Related]  

  • 3. A Survival Analysis of Patients with Recurrent Epithelial ovarian cancer Based on Relapse Type: A Multi-Institutional Retrospective Study in Armenia.
    Harutyunyan L; Manvelyan E; Karapetyan N; Bardakhchyan S; Jilavyan A; Tamamyan G; Avagyan A; Safaryan L; Zohrabyan D; Movsisyan N; Avinyan A; Galoyan A; Sargsyan M; Harutyunyan M; Nersoyan H; Stepanyan A; Galstyan A; Danielyan S; Muradyan A; Jilavyan G
    Curr Oncol; 2024 Mar; 31(3):1323-1334. PubMed ID: 38534933
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinicopathological features and surgical procedures of adnexal masses with abdominal pain in pediatric and adolescent patients.
    Liu Q; Li Z; Zhou H; Cao D; Yang J; Shen K; Lang J
    Orphanet J Rare Dis; 2024 Mar; 19(1):132. PubMed ID: 38515195
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Barclay ME; Johnson SA; Swann R; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; May L; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJS; Thomson CS; Wang H; Woods RR; You H; Lyratzopoulos G;
    Lancet Oncol; 2024 Mar; 25(3):338-351. PubMed ID: 38423048
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Evaluating the Prognostic Factors and Survival Rates of Endometrial cancer Patients in a Tertiary Referral Hospital in Northeast Thailand.
    Wannasin R; Thinkhamrop K; Kelly M; Likitdee N
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):671-679. PubMed ID: 38415555
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
    Ruiz F; Tjendra Y; Millan N; Gomez-Fernandez C; Pinto A
    Am J Surg Pathol; 2024 May; 48(5):546-550. PubMed ID: 38357982
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.
    Yu JH; Tong CJ; Huang QD; Ye YL; Chen G; Li H; Wen YS; Yang F; Luo NB; Xu GY; Xiong Y
    BMC Cancer; 2024 Jan; 24(1):88. PubMed ID: 38229045
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Swyer syndrome with gonadal non-dysgerminoma malignant germ cell tumors: a report of 15 cases in a national medical center].
    Liang H; Li SJ; Yang JX; Wu M; Cao DY; Wang JH; Wang T; Zhang XY
    Zhonghua Fu Chan Ke Za Zhi; 2024 Jan; 59(1):64-69. PubMed ID: 38228517
    [No Abstract]    [Full Text] [Related]  

  • 10. Long Non-Coding RNAs: Bridging cancer-Associated Thrombosis and Clinical Outcome of ovarian cancer Patients.
    Marques IS; Tavares V; Savva-Bordalo J; Rei M; Liz-Pimenta J; de Melo IG; Assis J; Pereira D; Medeiros R
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203310
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
    Young Han C; Bedia JS; Yang WL; Hawley SJ; Bergan L; Hopper M; Celestino J; Guo J; Gornet TG; Soosaipillai A; Yang H; Doskocil SD; Lokshin AE; Handy BC; Diamandis EP; Moore RG; Lu KH; Lu Z; Anderson KS; Drescher CW; Skates SJ; Bast RC
    Br J Cancer; 2024 Mar; 130(5):861-868. PubMed ID: 38195887
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mental health and diet quality after primary treatment for ovarian cancer.
    Johnston EA; Veenhuizen SGA; Ibiebele TI; Webb PM; van der Pols JC;
    Nutr Diet; 2024 Apr; 81(2):215-227. PubMed ID: 38192229
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The use of fertility treatments among reproductive-aged women after cancer.
    Kipling LM; Shandley LM; Mertens AC; Spencer JB; Howards PP
    Fertil Steril; 2024 Apr; 121(4):578-588. PubMed ID: 38103881
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic cancer.
    Khadraoui W; Meade CE; Backes FJ; Felix AS
    JAMA Netw Open; 2023 Dec; 6(12):e2346494. PubMed ID: 38060227
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pregnancy After Breast cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
    Lambertini M; Blondeaux E; Agostinetto E; Hamy AS; Kim HJ; Di Meglio A; Bernstein Molho R; Hilbers F; Pogoda K; Carrasco E; Punie K; Bajpai J; Ignatiadis M; Moore HCF; Phillips KA; Toss A; Rousset-Jablonski C; Peccatori FA; Renaud T; Ferrari A; Paluch-Shimon S; Fruscio R; Cui W; Wong SM; Vernieri C; Ruddy KJ; Dieci MV; Matikas A; Rozenblit M; Villarreal-Garza C; De Marchis L; Del Mastro L; Puglisi F; Del Pilar Estevez-Diz M; Rodriguez-Wallberg KA; Mrinakova B; Meister S; Livraghi L; Clatot F; Yerushalmi R; De Angelis C; Sánchez-Bayona R; Meattini I; Cichowska-Cwalinska N; Berlière M; Salama M; De Giorgi U; Sonnenblick A; Chiodi C; Lee YJ; Maria C; Azim HA; Boni L; Partridge AH;
    JAMA; 2024 Jan; 331(1):49-59. PubMed ID: 38059899
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A retrospective study of Pipelle endometrial biopsy for ovarian, fallopian tube, and peritoneal cancers.
    Tamura R; Kitani Y; Takahashi K; Yamaguchi M; Nishikawa N; Kawasaki T; Kikuchi A
    J Obstet Gynaecol; 2023 Dec; 43(2):2283162. PubMed ID: 37983014
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Proposal for targeted, neo-evolutionary-oriented, secondary prevention of early-onset endometriosis and adenomyosis. Part I: pathogenic aspects.
    Vercellini P; Bandini V; Viganò P; Di Stefano G; Merli CEM; Somigliana E
    Hum Reprod; 2024 Jan; 39(1):1-17. PubMed ID: 37951243
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions.
    Vercellini P; Bandini V; Viganò P; Ambruoso D; Cetera GE; Somigliana E
    Hum Reprod; 2024 Jan; 39(1):18-34. PubMed ID: 37951241
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. LncRNA
    Wang J; Han Y; Zhang T; Li J; Xu B
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):270. PubMed ID: 37919051
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Autoimmune and paraneoplastic neurological disorders: A review of relevant neuroimaging findings.
    Akkus S; Elkhooly M; Amatya S; Shrestha K; Sharma K; Kagzi Y; Khan E; Gupta R; Piquet AL; Jaiswal S; Wen S; Tapia M; Samant R; Sista SR; Sriwastava S
    J Neurol Sci; 2023 Nov; 454():120830. PubMed ID: 37856996
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 68.